Trial intelligence / Profile preview

Propofol versus Nesdonal for reduction of cerebral ischemia during neurosurgery

IRCT20250722066589N2Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of propofol and thiopental in brain ischemia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Started Aug 2025; status: completed.

02

Drugs

propofolthiopental
03

Conditions

brain ischemia

Beyond the preview

Go deeper on IRCT20250722066589N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250722066589N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call